Novartis' drug failure has negatively impacted Amgen's financial outlook.
2 reports, 2 independent
Updated Sep 9
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Novartis' drug failure has negatively impacted Amgen's financial outlook.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- The market is reacting to the news of Novartis' drug trial failures, specifically impacting Amgen's stock performance on the Nasdaq exchange.Sub-event
Novartis drug failure impacts Amgen's outlook.1 source